GILD241213P80000
- 0.00
- 0.000.00%
Gilead Sciences Newsroom
Gilead Sciences Price Target Maintained With a $80.00/Share by Cantor Fitzgerald
Leerink Partners Initiates Gilead Sciences(GILD.US) With Buy Rating, Announces Target Price $99
Market Climbs on CPI Inflation and Likelihood of Rate Cuts | Livestock
Express News | RBC Capital Reiterates Sector Perform on Gilead Sciences, Maintains $84 Price Target
Gilead Sciences Hits 4-week High
Jefferies Maintains Gilead Sciences(GILD.US) With Buy Rating, Raises Target Price to $115
Gilead Sciences (GILD) Receives a Buy From Jefferies
A Quick Look at Today's Ratings for Gilead Sciences(GILD.US), With a Forecast Between $105 to $125
Today's Analyst Rating | Broadcom Price Target Raised to $205 by Citi, Oracle Price Target Raised to $210 by UBS
Express News | Gilead : Leerink Partners Raises Target Price to $99 From $96
Gilead Sciences' Strategic Focus on Lenacapavir and Lifecycle Management Drives Buy Rating
BofA Restarts Coverage of 11 Large-cap Biopharmas
Unusual Options Activity: AI, MSTR and Others Attract Market Bets, AI V/OI Ratio Reaches 249.3
Market Falls Wednesday, but Googles Chip Impresses | WST
Google's Quantum Chip Might Have Contacted Parallel Universes | Live Stock
Editas Stock Rises on Updated Data From SCD Study of Reni-Cel
KOD Stock Up as Jefferies Upgrades Rating on Huge Pipeline Potential
Citi Maintains Gilead Sciences(GILD.US) With Buy Rating
Express News | B of A Securities Reinstates Buy on Gilead Sciences, Announces $109 Price Target
Citi Remains a Buy on Gilead Sciences (GILD)